{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:05:17Z","timestamp":1761919517455,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.msard.2011.12.001","type":"journal-article","created":{"date-parts":[[2012,1,18]],"date-time":"2012-01-18T04:50:25Z","timestamp":1326862225000},"page":"59-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multiple sclerosis and risk behavior"],"prefix":"10.1016","volume":"1","author":[{"given":"Christopher H.","family":"Hawkes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2011.12.001_bib1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/1352458508100967","article-title":"Therapy-related acute leukaemia with Mitoxantrone: what is the risk and can we minimise it?","volume":"15","author":"Ellis","year":"2009","journal-title":"Multiple Sclerosis"},{"key":"10.1016\/j.msard.2011.12.001_bib2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/qjmed\/hci135","article-title":"Are multiple sclerosis patients risk-takers?","volume":"98","author":"Hawkes","year":"2005","journal-title":"QJM"},{"key":"10.1016\/j.msard.2011.12.001_bib3","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1177\/1352458510379819","article-title":"Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists","volume":"16","author":"Heesen","year":"2010","journal-title":"Multiple Sclerosis"},{"key":"10.1016\/j.msard.2011.12.001_bib4","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s00415-009-0084-2","article-title":"Multiple sclerosis patients\u2019 benefit-risk preferences: serious adverse event risks versus treatment efficacy","volume":"256","author":"Johnson","year":"2009","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.msard.2011.12.001_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/1352458508096680","article-title":"High frequency of adverse health behaviors in multiple sclerosis","volume":"15","author":"Marrie","year":"2009","journal-title":"Multiple Sclerosis"},{"key":"10.1016\/j.msard.2011.12.001_bib6","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1212\/WNL.0b013e3181dc1ae0","article-title":"Evidence report: the efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"74","author":"Marriott","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2011.12.001_bib7","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/oxfordjournals.aje.a008941","article-title":"Evidence against the operation of selective mortality in explaining the association between cigarette smoking and reduced occurrence of idiopathic Parkinson disease","volume":"144","author":"Morens","year":"1996","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.msard.2011.12.001_bib8","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.45.6.1041","article-title":"Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue?","volume":"45","author":"Morens","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2011.12.001_bib9","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1177\/0272989X02238299","article-title":"The relationship between risk attitude and treatment choice in patients with relapsing-remitting multiple sclerosis","volume":"22","author":"Prosser","year":"2002","journal-title":"Medical Decision Making"},{"key":"10.1016\/j.msard.2011.12.001_bib10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/0272989X07300602","article-title":"Do risk attitudes differ across domains and respondent types?","volume":"27","author":"Prosser","year":"2007","journal-title":"Medical Decision Making"},{"key":"10.1016\/j.msard.2011.12.001_bib11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1474-4422(10)70094-6","article-title":"Multiple sclerosis: risk factors, prodromes, and potential causal pathways","volume":"9","author":"Ramagopalan","year":"2010","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.msard.2011.12.001_bib12","article-title":"Negative interaction between smoking and infectious mononucleosis and the risk of MS","volume":"17","author":"Riise","year":"2011","journal-title":"Multiple Sclerosis Journal"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103481100037X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103481100037X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:34:46Z","timestamp":1761899686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103481100037X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S221103481100037X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2011.12.001","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple sclerosis and risk behavior","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2011.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}